RGACX
Price
$64.89
Change
+$1.02 (+1.60%)
Updated
Apr 11 closing price
Net Assets
260.89B
RGRYX
Price
$28.83
Change
+$0.54 (+1.91%)
Updated
Apr 11 closing price
Net Assets
287.61M
Ad is loading...

RGACX vs RGRYX

Header iconRGACX vs RGRYX Comparison
Open Charts RGACX vs RGRYXBanner chart's image
American Funds Growth Fund of Amer R3
Price$64.89
Change+$1.02 (+1.60%)
VolumeN/A
Net Assets260.89B
Victory RS Growth Y
Price$28.83
Change+$0.54 (+1.91%)
VolumeN/A
Net Assets287.61M
RGACX vs RGRYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGACX vs. RGRYX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a Buy and RGRYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 261B vs. RGRYX (288M). RGACX pays higher dividends than RGRYX: RGACX (0.09) vs RGRYX (0.00). RGACX was incepted earlier than RGRYX: RGACX (23 years) vs RGRYX (18 years). RGRYX (0.97) and RGACX (0.94) have similar cost to investors . RGRYX is a more actively managed with annual turnover of: 62.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than RGRYX: RGACX (250) vs RGRYX (1000000). RGACX (-5.75) and RGRYX (-5.79) have marching annual gain over last year. RGRYX return over 5 years is better than : 59.62 vs. RGACX (44.89).
RGACXRGRYXRGACX / RGRYX
Total Expense Ratio0.940.83113%
Annual Report Gross Expense Ratio0.940.9797%
Fund Existence23 years18 years-
Gain YTD-9.862-14.68667%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets261B288M90,625%
Annual Yield % from dividends0.090.00-
Returns for 1 year-5.75-5.7999%
Returns for 3 years5.7619.7729%
Returns for 5 years44.8959.6275%
Returns for 10 years47.5148.5198%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LKQ42.010.90
+2.19%
LKQ Corp
INDP0.48N/A
N/A
Indaptus Therapeutics
EGBN18.97-0.32
-1.66%
Eagle Bancorp
PENN14.33-0.36
-2.45%
PENN Entertainment
BDSX0.53-0.04
-7.02%
Biodesix